Liu Chengyao, Han Demin, Zhang Luo, Zhao Yan
Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009 Jun;23(11):484-7.
To evaluate the diagnostic performance of the AllergyScreen system from Mediwiss An alytic GmbH and the Pharmacia CAP system from Pharmacia Diagnostics for the detection of four inhalant allergens in the diagnosis of allergic rhinitis.
All 35 serum samples were collected from patients who were referred to the allergist for a suspected allergic rhinitis between January to March in 2007. Patients were classified as study diagnosis-positive for inhalant allergy if they both had a positive clinical examination/history and a related positive skin test for the suspected inhalant allergen.
Comparing with the reference standard, the diagnostic indexes (sensitivity, specificity, accuracy, predictive value of positive, and predictive value of negative) of the CAP system and the AllergyScreen system were 0.96 vs 0.89, 0.84 vs 0.75, 0.89 vs 0.80, 0.78 vs 0.65 and 0.93 vs 0.93 respectively. The CAP system method had higher sensitivity, specificity and accuracy than AllergyScreen system method, but there have no statistical difference between two systems (P>0.05).
This data support the use of ImmunoCAP system and AllergyScreen system to identify potentially significant individual allergens in the diagnosis of allergic rhinitis. The diagnostic indexes between the two systems have no statistical difference. As a simple, rapid turnaround time and low-cost system, AllergyScreen system can test multi-allergens in one time, so it can be used as a complementary with the ImmunoCAP system.
评估德国Mediwiss Analytic GmbH公司的AllergyScreen系统和法玛西亚诊断公司的法玛西亚CAP系统在过敏性鼻炎诊断中检测四种吸入性过敏原的诊断性能。
所有35份血清样本均采集自2007年1月至3月间因疑似过敏性鼻炎转诊至过敏症专科医生处的患者。如果患者临床检查/病史呈阳性且对疑似吸入性过敏原的皮肤试验相关结果呈阳性,则被分类为吸入性过敏研究诊断阳性。
与参考标准相比,CAP系统和AllergyScreen系统的诊断指标(敏感性、特异性、准确性、阳性预测值和阴性预测值)分别为0.96对0.89、0.84对0.75、0.89对0.80、0.78对0.65和0.93对0.93。CAP系统方法的敏感性、特异性和准确性高于AllergyScreen系统方法,但两个系统之间无统计学差异(P>0.05)。
这些数据支持使用免疫CAP系统和AllergyScreen系统在过敏性鼻炎诊断中识别潜在的重要个体过敏原。两个系统之间的诊断指标无统计学差异。作为一种简单、周转时间短且成本低的系统,AllergyScreen系统可一次性检测多种过敏原,因此可作为免疫CAP系统的补充。